Bourse Direct SA (EPA:BSD)

Regulus Therapeutics Revenue

Bourse Direct had revenue of 37.20M EUR in the half year ending June 30, 2025, with 11.47% growth. This brings the company's revenue in the last twelve months to 73.18M, up 2.23% year-over-year. In the year 2024, Bourse Direct had annual revenue of 74.38M with 11.95% growth.

• Revenue (ttm): 73.18M
• Revenue Growth: +2.23%
• P/S Ratio: 3.03
• Revenue / Employee: 501.23K
• Employees: 146
• Market Cap: 221.92M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	74.38M	7.94M	11.95%
Dec 31, 2023	66.44M	18.46M	38.49%
Dec 31, 2022	47.98M	1.66M	3.58%
Dec 31, 2021	46.32M	1.39M	3.10%
Dec 31, 2020	44.93M	12.97M	40.58%